Former President & Chief Executive Officer · XBiotech Inc. (XBIT)

John Simard

A named executive officer of XBiotech in every fiscal year CompBrief holds from FY2017 to FY2025. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2025

$30,134,204

Salary $1,250,000Stock awards $0Bonus $8,530,442

FY2024: $6,245,581

1st of 3 named executive officers at XBiotech by FY2025 total.

3 named officers on file for XBiotech, FY2025

John Simard’s pay file — $29

  • 9 fiscal years of pay, line by line
  • 4 equity grants, each cited to its filing

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how XBiotech’s whole pay program stands against its peers

  • XBiotech’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on XBIT→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed October 2, 2026 (DEF 14A). Insider transactions since that proxy, current to 2026-11-21.

Free

Get John Simard’s full pay file as a PDF — free

More than this page: up to 10 years of John’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

John Simard compensation by year

XBiotech Summary Compensation Table · all 9 fiscal years held
In US dollars, as XBiotech reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Salary$566,440$585,002$590,896$683,650$776,598$881,440$1,065,440$1,205,083$1,250,000
Bonus$0$193,000$228,000$2,728,000$7,000,000$3,780,000$4,480,000$5,030,000$8,530,442
Stock awards$0$0$0$0$0$0$0$0$0
Option awards$127,917$148,000$9,982,497——$0$0$0$3,000,000
Non-equity incentive$0$0$0$0$0$0$0$0$0
Pension and deferred compensation$0$0$0$0$0$0$0$0$0
All other$7,195$8,969$8,969$10,055$8,955$9,494$11,041$10,498$17,353,762
Total$701,552$934,971$10,810,362$3,421,705$7,785,554$4,670,934$5,556,481$6,245,581$30,134,204

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: XBiotech Inc. DEF 14A filed October 2, 2026, accession 0001171843-26-006362, and prior-year filings. Open the filing on EDGAR.

How this page was built: the XBiotech Inc. filed document, accession 0001171843-26-006362. Every figure is read from that document and cited to the page and table it appears in. Filed October 2, 2026.

$702K
$935K
$10.8M
$3.4M
$7.8M
$4.7M
$5.6M
$6.2M
$30.1M
FY17
FY18
FY19
FY20
FY21
FY22
FY23
FY24
FY25
SalaryBonusOption awardsAll other

Insider transactions since the last proxy

2 Form 4 lines since the FY2025 proxy (filed October 2, 2026)
current to 2026-11-21 · updated nightly
DateTransactionPlanSharesPriceHeld after
2026-11-03Purchase—70,000$2.054,261,690
2026-10-26Purchase—368,524$1.934,191,690

The 2 most recent of 2 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →

XBiotech’s named executive officers, FY2025

as the company reported each
Named executive officerRoleFY2025 total
John Simard · this pageFormer President & Chief Executive Officer$30,134,204
Sushma ShivaswamyInterim Chief Executive Officer & Chief Scientific Officer$570,992
Angela HuDirector of Finance$245,419

The full XBiotech compensation record

free company brief

This page is one person within XBiotech's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are XBiotech's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

John Simard's compensation dossier · One-time report. No refunds.